Depressive symptoms and oral contraceptives

Area of Science:

• Reproductive Health
• Mental Health
• Pharmacology

Background:

• Depression is a common mental health concern.
• Contraceptive methods, including oral contraceptives (OCs), are widely used by women.
• Understanding the potential mental health impacts of different contraceptive methods is crucial.

Purpose of the Study:

• To investigate the relationship between contraceptive methods and depression.
• To compare depression levels between women using oral contraceptives and those using physical contraception.
• To examine the impact of specific oral contraceptive formulations on mood.

Main Methods:

• A self-rating depression scale was administered to 261 women.
• Participants were categorized into oral contraceptive users (168) and physical contraception users (93).
• Depression levels were analyzed in relation to contraceptive type and menstrual cycle phase.

Main Results:

• Women using oral contraceptives showed a higher incidence of severe depression (6.6%) compared to controls.
• Depression varied significantly with the menstrual cycle in the control group but not in the OC group.
• A specific OC formulation (lynestrenol 2.5 mg and mestranol 0.075 mg) was linked to increased pessimism, dissatisfaction, crying, and tension.

Conclusions:

• Oral contraceptives may be associated with an increased risk of depression in some women.
• The specific formulation of oral contraceptives can influence the type and severity of mood disturbances.
• Further research is warranted to understand the mechanisms and individual variability in OC-related mood changes.